1220329-26-9

Basic information

• Product Name: (3aR,5R,7aS)-5-(benzyloxymethyl)-7a-(5-bromo-2-fluorophenyl)-1,3,3a,4,5,7-hexahydropyrano[3,4-c]isoxazole
• Synonyms: (3aR,5R,7aS)-5-(benzyloxymethyl)-7a-(5-bromo-2-fluorophenyl)-1,3,3a,4,5,7-hexahydropyrano[3,4-c]isoxazole
• CAS NO: 1220329-26-9
• Molecular Weight: 422.294
• Mol File: 1220329-26-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (3aR,5R,7aS)-5-(benzyloxymethyl)-7a-(5-bromo-2-fluorophenyl)-1,3,3a,4,5,7-hexahydropyrano[3,4-c]isoxazole(CAS DataBase Reference)
• NIST Chemistry Reference: (3aR,5R,7aS)-5-(benzyloxymethyl)-7a-(5-bromo-2-fluorophenyl)-1,3,3a,4,5,7-hexahydropyrano[3,4-c]isoxazole(1220329-26-9)
• EPA Substance Registry System: (3aR,5R,7aS)-5-(benzyloxymethyl)-7a-(5-bromo-2-fluorophenyl)-1,3,3a,4,5,7-hexahydropyrano[3,4-c]isoxazole(1220329-26-9)

Safety Data

• Hazardous Substances Data: 1220329-26-9(Hazardous Substances Data)

Upstream product

• 1220328-95-9 2-{[(2R)-1-(benzyloxy)pent-4-en-2-yl]oxy}-N-hydroxyethanimine 
• 116272-41-4 4-bromo-1-fluoro-2-iodobenzene 
• 1220328-97-1 (3aR,5R)-5-[(benzyloxy)methyl]-3,3a,4,5-tetrahydro-7H-pyrano[3,4-c][1,2]oxazole 
• 1220328-94-8 ({[(2R)-2-(2,2-diethoxyethoxy)pent-4-en-1-yl]oxy}methyl)benzene 
• 58931-16-1 (R)-1-benzyloxypent-4-en-2-ol 
• 1435-53-6 2,4-dibromo-1-fluorobenzene 

Downstream Products

• 1220329-28-1 [(2R,4R,5S)-5-amino-2-[(benzyloxy)methyl]-5-(5-bromo-2-fluorophenyl)tetrahydro-2H-pyran-4-yl]methanol 
• 1613393-90-0 N-{[(3S,4R,6R)-6-[(benzyloxy)methyl]-3-(5-bromo-2-fluorophenyl)-4-(hydroxymethyl)tetrahydro-2H-pyran-3-yl]carbamothioyl}benzamide 
• 1613393-91-1 N-[(4aR,6R,8aS)-6-[(benzyloxy)methyl]-8a-(5-bromo-2-fluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-d][1,3]thiazin-2-yl]benzamide 
• 1613393-92-2 N-[(4aR,6R,8aS)-8a-(5-bromo-2-fluorophenyl)-6-(hydroxymethyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-d][1,3]thiazin-2-yl]benzamide 
• 1613393-93-3 (4aR,6R,8aS)-2-(benzoylamino)-8a-(5-bromo-2-fluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-d][1,3]thiazine-6-carboxylic acid 
• 1613393-94-4 methyl (4aR,6R,8aS)-2-(benzoylamino)-8a-(5-bromo-2-fluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-d][1,3]thiazine-6-carboxylate 
• 1613393-95-5 N-[(4aR,6R,8aS)-8a-(5-bromo-2-fluorophenyl)-6-(3-methyl-1,2-oxazol-5-yl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-d][1,3]thiazin-2-yl]benzamide 
• 1613393-96-6 N-[(4aR,6R,8aS)-8a-(5-cyano-2-fluorophenyl)-6-(3-methyl-1,2-oxazol-5-yl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-d][1,3]thiazin-2-yl]benzamide 
• 1613393-89-7 3-[(4aR,6R,8aS)-2-amino-6-(3-methyl-1,2-oxazol-5-yl)-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl]-4-fluorobenzonitrile 
• 1613393-98-8 (4aR,6R,8aS)-2-(benzoylamino)-8a-(5-bromo-2-fluorophenyl)-N-(1-hydroxypropan-2-yl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-d][1,3]thiazine-6-carboxamide 
• 1613393-99-9 (4aR,6R,8aS)-2-(benzoylamino)-8a-(5-bromo-2-fluorophenyl)-N-(1-oxopropan-2-yl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-d][1,3]thiazine-6-carboxamide 
• 1613394-00-5 N-[(4aR,6R,8aS)-8a-(5-bromo-2-fluorophenyl)-6-(4-methyl-1,3-oxazol-2-yl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-d][1,3]thiazin-2-yl]benzamide 
• 1613394-03-8 N-[(4aR,6R,8aS)-8a-(5-bromo-2-fluorophenyl)-6-formyl-4,4a,5,6,8,8a-hexahydropyrano[3,4-d][1,3]thiazin-2-yl]benzamide 
• 1613394-04-9 N-{(4aR,6R,8aS)-8a-(5-bromo-2-fluorophenyl)-6-[(E)-2-methoxyethenyl]-4,4a,5,6,8,8a-hexahydropyrano[3,4-d][1,3]thiazin-2-yl}benzamide 

Relevant articles and documents

AMINOTHIAZINES AND THEIR USE AS BACE1 INHIBITORS

The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases and disorders, such as Alzheimer's disease.

HEXAHYDROPYRANO[3,4-d][1,3]THIAZIN-2-AMINE COMPOUNDS

The present invention provides compounds of Formula I, and the tautomers thereof, and the pharmaceutically acceptable salts of the compounds and tautomers, wherein the compounds have the structure wherein the variables R1, R2, R3, R4 and x are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.